Tirzepatide

Research focusWeight loss & glucose

€64.00Currently unavailable

Laboratory research only · Not for human use

Select size 5 mg

Out of stock

5 mg · Single vial

Compound profile

RESEARCH AT A GLANCE

Tirzepatide, made clearer.

Learn

Research topicWeight loss & glucose

EvidenceHuman studies

In our library1 linked study

Research areas describe what is studied. They do not promise a benefit.

What researchers study

A GIP and GLP-1 receptor agonist evaluated in large randomized human studies of metabolic disease.

CompoundIdentity matters

Study modelMetabolic physiology

ObservationA measured outcome

Acts at the GIP and GLP-1 receptors; outcomes depend on the studied population and specific medicinal product.

Conceptual study process

Evidence & sources

Some research involves people. Study population, measured outcomes, and trial conditions determine what the findings mean.

CURATED LIBRARY

Linked study types

1 linked study

Library counts only. This is not an effectiveness score or a complete research review.

Human randomized trial2022

Tirzepatide Once Weekly for the Treatment of Obesity

A 72-week randomized trial enrolled 2,539 adults with obesity or overweight and a weight-related complication, excluding diabetes. Tirzepatide groups had greater average weight reduction than placebo.

Study limitations

Results apply to the enrolled population and monitored trial conditions. Gastrointestinal adverse events and treatment discontinuations matter alongside efficacy; these findings do not establish the quality or safety of unregulated products.

Study notes Original publication

Profile referencesfda.gov Reference 1

Limitations & safety

This listing does not establish human safety or treatment benefit.

Clinical benefit and long-term safety are not established by the evidence curated here.
Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.

Full profile Evidence tiers Storage guide

Product details

A GIP and GLP-1 receptor agonist evaluated in large randomized human studies of metabolic disease.

Check batch documentation and laboratory characterization for the supplied product. Published research does not validate this vial’s quality, safety or efficacy.

SKU: PYN-TIRZEPATIDE-5MG5 mg · Single vial

Shipping & orders

Shipping costs and payment options appear at checkout. Follow the instructions saved with your order; our team verifies payment before shipping. Tracking updates appear in your account.

Your orders